Interdepartmental Biological Sciences Program, Department of Chemistry, and International Institute for Nanotechnology, Northwestern University, Evanston, Illinois, USA.
Bioconjug Chem. 2010 Dec 15;21(12):2250-6. doi: 10.1021/bc1002423. Epub 2010 Nov 11.
Mammalian cells have been shown to internalize oligonucleotide-functionalized gold nanoparticles (DNA-Au NPs or siRNA-Au NPs) without the aid of auxiliary transfection agents and use them to initiate an antisense or RNAi response. Previous studies have shown that the dense monolayer of oligonucleotides on the nanoparticle leads to the adsorption of serum proteins and facilitates cellular uptake. Here, we show that serum proteins generally act to inhibit cellular uptake of DNA-Au NPs. We identify the pathway for DNA-Au NP entry in HeLa cells. Biochemical analyses indicate that DNA-Au NPs are taken up by a process involving receptor-mediated endocytosis. Evidence shows that DNA-Au NP entry is primarily mediated by scavenger receptors, a class of pattern-recognition receptors. This uptake mechanism appears to be conserved across species, as blocking the same receptors in mouse cells also disrupted DNA-Au NP entry. Polyvalent nanoparticles functionalized with siRNA are shown to enter through the same pathway. Thus, scavenger receptors are required for cellular uptake of polyvalent oligonucleotide functionalized nanoparticles.
已经证明,哺乳动物细胞可以在没有辅助转染试剂的情况下内化寡核苷酸功能化的金纳米颗粒(DNA-Au NPs 或 siRNA-Au NPs),并利用它们引发反义或 RNAi 反应。先前的研究表明,纳米颗粒上寡核苷酸的密集单层导致血清蛋白的吸附并促进细胞摄取。在这里,我们表明血清蛋白通常会抑制 DNA-Au NPs 的细胞摄取。我们确定了 HeLa 细胞中 DNA-Au NP 进入的途径。生化分析表明,DNA-Au NPs 通过涉及受体介导的内吞作用的过程被摄取。有证据表明,DNA-Au NP 的进入主要由清道夫受体介导,清道夫受体是一类模式识别受体。这种摄取机制似乎在物种间是保守的,因为在小鼠细胞中阻断相同的受体也会破坏 DNA-Au NP 的进入。用 siRNA 功能化的多价纳米颗粒被证明通过相同的途径进入。因此,多价寡核苷酸功能化纳米颗粒的细胞摄取需要清道夫受体。